Frontlight ResearchEarly access
Taking peopleNo phase
Trauma Molecular Processes
Key facts
- Who runs it
- Mario Negri Institute for Pharmacological Research
- Where
- Italy2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 18 Oct 2024
- Expected to end
- Oct 2044
- Type of study
- Observational
- Record updated
- 6 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Adults aged ≥18 years
- Diagnosis of traumatic brain injury (TBI)
- Admission to the intensive care unit
- Clinical indication for neurosurgical evacuation of a cerebral contusion
- Written informed consent to participate to the study
Who cannot take part
- Coagulation disorders or other contraindications to the planned neurosurgical procedure
This trial is currently available in Italy.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The TRAUMAP study will function as a brain tissue repository for biopsy specimens from patients with traumatic brain injury undergoing brain surgery for contusion removal.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Study of Pathological and Regenerative Molecular and Cellular Processes Triggered After Traumatic Brain Injury: Analysis of Biopsy Specimens
- Record updated
- 6 July 2026